A Phase 1, randomized, double-blind, placebo-controlled, 5 arm, parallel group study of the safety, tolerability and pharmacokinetics of oral BTD-001 in 30 male and female healthy volunteers

Trial Profile

A Phase 1, randomized, double-blind, placebo-controlled, 5 arm, parallel group study of the safety, tolerability and pharmacokinetics of oral BTD-001 in 30 male and female healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Jun 2016

At a glance

  • Drugs Pentylenetetrazole (Primary)
  • Indications Cognition disorders; Down syndrome
  • Focus Adverse reactions
  • Most Recent Events

    • 06 Dec 2013 Status changed from active, no longer recruiting to completed as reported by Australian New Zealand Clinical Trials Registry.
    • 19 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top